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Neutrophil-specific granule deficiency (SGD) is a rare autosomal recessive 
primary immunodeficiency characterized by neutrophil dysfunction, bilobed neutrophil 
nuclei and lack of neutrophil-specific granules. Defects in a myeloid-specific 
transcription factor, CCAAT/enhancer binding protein-epsilon (C/EBPε), have been 
identified in two cases where homozygous frameshift mutations lead to loss of the leucine 
zipper domain. Here, we report a 55-year-old female affected with SGD caused by a 
novel homozygous 2-amino-acid deletion (ΔRS) in the leucine zipper domain of the 
C/EBPε gene. The patient showed characteristic neutrophil abnormalities and recurrent 
skin infections, however, there was no history of deep organ infections. Biochemical 
analysis revealed that, in contrast to the two frameshift mutations, the ΔRS mutant 
maintained normal cellular localization, DNA-binding activity and dimerization, and all 
three mutants exhibited marked reduction in transcriptional activity. The ΔRS mutant was 
defective in its association with Gata1 and PU.1, as well as aberrant cooperative 
transcriptional activation of eosinophil major basic protein. Thus, the ΔRS likely impairs 
protein-protein interaction with other transcription factors resulting in a loss of 
transcriptional activation. These results further support the importance of the leucine 
zipper domain of C/EBPε for its essential function, and indicate that multiple molecular 





Neutrophil-specific granule deficiency (SGD) is a rare autosomal recessive 
primary immunodeficiency characterized by either profound reduction or absence of 
neutrophil-specific granules and bilobed neutrophil nuclei (pseudo-Pelgar-Huët anomaly) 
(1). It was previously called lactoferrin deficiency. Patients with SGD present with 
increased susceptibility to bacterial infections, especially affecting the skin, ears, lungs 
and lymph nodes. The gene responsible for SGD is the CCAAT/enhancer binding 
protein-epsilon (C/EBPε) gene. To date, two patients have been reported who carry 
C/EBPε frameshift mutations that result in abrogated protein expression (2, 3). In 
addition, another patient with SGD had a heterozygous missense mutation of the C/EBPε 
gene, but this mutation was unlikely to have caused disease because it resulted in elevated 
levels of C/EBPε (4). In this patient, the growth factor independence 1 (Gfi-1) protein 
that represses transcription of C/EBPε was decreased, although the patient had no 
mutation of the Gfi-1 gene. Taken together, these previous findings suggest that SGD is a 
genetically heterogeneous disease. Because of SGD’s extreme rarity, how wide the 
spectrum of clinical symptoms and cellular abnormalities of the disease is unclear. 
C/EBPε is a member of the C/EBP family of widely expressed transcription 
factors that regulate proliferation, differentiation and apoptosis in a variety of cell types 
(5, 6). The C/EBP family consists of 6 members (C/EBPα, β, γ, δ, ε and ζ), and cellular 
expression of each C/EBP is tightly regulated. They bind to DNA through the highly 
conserved basic leucine zipper (bZIP) domain. C/EBPε is restricted to granulocytes and is 
essential for their terminal differentiation (6, 7). C/EBPε transcription primarily occurs at 
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the myelocyte/metamyelocyte stage of differentiation and decreases in 
polymorphonuclear neutrophils. The human C/EBPε gene produces 4 isoforms of 32, 30, 
27 and 14 kDa, which are functionally different; only the 32 kDa C/EBPε has full 
transactivating potential (8-10). C/EBPε is indispensable for expression of genes 
encoding proteins that reside in specific granules of neutrophils such as lactoferrin and 
defensins. Many features of SGD are manifested by C/EBPε-deficient mice in which 
neutrophils are morphologically and functionally abnormal and eosinophil numbers are 
decreased (8). 
Here, we describe another case of SGD with a novel two amino-acid (aa) deletion 
in the bZIP domain of C/EBPε, and report the mechanism that leads to SGD. We also 
carried out clinical, cellular and molecular comparisons among this patient and the 




Materials and Methods 
 
Patients 
We studied two Japanese patients with SGD. Patient P1 is a 55-year-old female 
who has suffered since late infancy from recurrent skin infections that often required 
more than 2 months to heal. After hospitalization due to severe otitis media at 54 years of 
age, she was referred to our hospital for suspected immunodeficiency. A history of 
parental consanguinity appeared likely. However, her farther had already died of a heart 
attack, and her mother refused genetic analysis. Her elder brother had similar skin 
symptoms and died of enterocolitis at 10 years of age. Another brother also died early 
after birth from unspecified causes. Two children of patient P1 and her granddaughter 
were healthy and they did not want genetic testing. Clinical and genetic data of patient P2 
have already been published (3, 11). Patient P2 is now 40 years old. Approval for the 
study was obtained from the Human Research Committee of Kanazawa University 
Graduate School of Medical Science, and informed consent was provided according to 
the Declaration of Helsinki. 
 
Flow cytometry and immunohistochemistry 
For flow cytometric analysis the following mAbs were used: FITC-conjugated 
anti-CD16, anti-CD32 or CD66b and PE-conjugated anti-CD11b, anti-CD14, anti-CD15 
anti-CD16 or anti-CD64 (BD, San Diego, CA); and FITC-conjugated anti-CD16b and 
PE-conjugated CD11c (Beckman Coulter, Fullerton, CA). Analysis was performed on a 
FACSCalibur using CellQuest software (BD Bioscience, Tokyo, Japan) (12). Cytospin 
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preparations were made using whole leukocytes. For lactoferrin staining, cytospin 
samples were stained with anti-lactoferrin mAb (Beckman Coulter), followed by 
universal immuno-alkaline-phosphatase polymer (Simple Stain AP; Nichirei Biosciences, 
Tokyo, Japan). The alkaline phosphatase activity was visualized using Fast Red TR salt 
and Naphtol AS-MX phosphate (Sigma-Aldrich, St. Louis, MO). For analysis of internal 
alkaline phosphatase and peroxidase activity, alkaline phosphatase substrate solution 
(BCIP/NBT Substrate system, DAKO, Glostrup, Denmark) and a peroxidase staining kit 
(Muto Pure Chemicals Co., Ltd, Tokyo, Japan) were used, respectively. 
 
Mutation analysis 
Peripheral blood and/or buccal mucosa samples were obtained from patients, and 
DNA was extracted from the samples using a standard method. Direct sequencing of the 
C/EBPε gene was performed as described previously (2). 
 
Cell culture and RT-PCR 
Human embryonic kidney (HEK) 293 and mouse NIH3T3 cells were cultured in 
Dulbecco’s modified Eagle’s medium containing either 10% fetal bovine serum or 10% 
calf serum, respectively. Total RNA was extracted from transfected NIH3T3 cells with 
Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, Japan) and converted to cDNAs by 
ReverTraAce (Toyobo, Tokyo, Japan). Expression of human C/EBPε and PU.1, and 
murine cathelicidin B9/neutrophil granule protein (NGP), neutrophil gelatinase-
associated lipocalin (NGAL)/ lipocalin 2 (Lcn2), lactoferrin, proteoglycan 2 
(Prg2)/eosinophil granule eosinophil major basic protein (MaBP), GATA binding protein 
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1 (Gata1), and GAPDH was examined by RT-PCR. Primer sequences are reported in 
Table S1. The number of amplification cycles was 20 for GAPDH, 25 for C/EBPε, PU.1, 
MaBP and Gata1, 30 for B9 and NGAL, and 35 for lactoferrin. The PCR cycle consisted 
of 94°C for 15 sec, 60°C for 30 sec, and 72°C for 30 sec. For lactoferrin, the annealing 
temperature was 64°C. All PCR reactions were carried out with Taq polymerase 
(Ampliqon, Odense, Denmark) except for C/EBPε (PrimeSTAR Max DNA polymerase, 
Takara bio, Otsu, Japan). 
 
Construction of plasmid, luciferase assay and cellular localization 
Construction of mammalian expression vectors, including pCMV5-Flag- maltose-
binding protein (MBP), pCAGIP-enhanced GFP, and pCAGIP-Myc, was described 
previously (13, 14). Coding region of wild-type human C/EBPε and its mutants, ΔRS, 
del5bp and insA, were amplified by PCR using specific primers (Table S1) and cloned 
into expression vectors. Murine Gata1 and human PU.1 expression vectors were 
described previously (15), and their coding regions were cloned into the pCAGIP-Myc 
vector. The luciferase reporter plasmid containing the G-CSF receptor promoter 
(pGCSFR-Luc) has been described before (16). The reporter plasmid, C/EBPε and 
C/EBPε mutant expression vectors (ΔRS, del5bp and insA), were transfected into 
HEK293 cells by Lipofectamine 2000 (Life Technologies, Grand Island, NY). To 
determine luciferase activity, cell extracts were prepared 48 h after transfection, and 
luciferase activity was measured with a luciferase assay kit (Promega, Madison, WI) 
using an AB-2200 luminometer (ATTO, Tokyo, Japan). Protein concentration of each 
sample was measured by Protein Assay CBB solution (Nacalai Tesque). Relative 
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luciferase activity per 1 µg protein was represented. To observe cellular localization of 
C/EBPε and its mutants, GFP-tagged fusion protein expression vectors were introduced 
into NIH3T3 cells. Nuclei were stained by Hoechst 33258 (Sigma). Signals were 
observed 48 h after transfection. 
 
Biotin-labeled DNA pull-down assay, MBP pull-down assay and Western blot analysis 
Biotin-labeled DNA pull-down assay was performed as previously described (13, 
17). Briefly, biotin-labeled oligonucleotides containing the human lactoferrin gene 
C/EBPε binding site (5’-GGGTGTCTATTGGGCAACAGGGCGGG-3’) were incubated 
with cell extracts from HEK293 cells transfected with either pCAGIP-Myc-C/EBPε or its 
mutant counterparts  (ΔRS, del5bp and insA) in the presence of streptavidin-agarose 
(Novagen, Darmstadt, Germany). Twenty-five-fold non-labeled oligonucleotides (either 
wild-type or mutant non-binding control) were added for the competition assays. The 
beads were washed 3 times with a washing buffer, and the bound proteins were eluted by 
boiling in 2 x SDS sample buffer. Samples were then examined by Western blot analysis 
as described below. MBP pull-down assay was performed as previously described (13, 
17). HEK293 cells were cotransfected with pCAGIP-Myc-C/EBPε (wild-type or ΔRS) 
and  pCMV5-Flag-MBP-C/EBPε (wild-type or ΔRS). HEK293 cells were also 
cotransfected with pCAGIP-Myc-Gata1 and pCMV5-Flag-MBP-C/EBPε or its mutant 
counterparts, or with pCAGIP-Myc-PU.1 and pCMV5-Flag-MBP-C/EBPε or its mutant 
counterparts. MBP-fused proteins were pulled down by amylose resin, and the 
precipitates were analyzed by Western blot analysis. For Western blot analysis, samples 
were subjected to SDS-PAGE and transferred to a nitrocellulose membrane.  The 
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membrane was incubated with either anti-Myc (sc-40; Santa Cruz Biotechnology, Santa 
Cruz, CA) or anti-Flag (F3165; Sigma–Aldrich) Abs followed by horseradish peroxidase-
conjugated anti-mouse Ab (Millipore, Billerica, MA). The blot was visualized using 
enhanced chemiluminescence reagents (PerkinElmer, Waltham, MA) with an LAS-1000 





Bilobed nucleus and lack of granules in neutrophils 
Patient P1 presented with an ulcerative skin abscess and numerous skin scars (Fig. 
1A,B). Her peripheral blood smear showed unique bilobed nuclei and lack of cytoplasmic 
granules in her neutrophils (Fig. 1C). Absence of eosinophils, increased basophils with 
normal cytoplasmic granularity, and monocytosis were also noted on smears of the 
peripheral blood (data not shown). The immunohistochemical analysis of her neutrophils 
clearly demonstrated the presence of peroxidase, a primary granule protein, and the 
absence of lactoferrin and alkaline phosphatase, both of which are normally expressed in 
specific granules of normal neutrophils (Fig. 1D). These characteristic features were quite 
similar to those of patient P2, the second case of genetically defined SGD, who carries a 
homozygous C/EBPε mutation, c.508_509insA (insA) (3). 
Flow cytometric analysis of peripheral blood showed lower side scatter of P1 
neutrophils compared to normal controls (Fig. 2) (18). More importantly, the majority of 
the patient’s neutrophils that were defined on the basis of forward and side scatter 
expressed a monocyte marker CD14, indicating aberrant development toward the 
monocyte pathway. These cells did not express neutrophil markers such as CD15, CD16b 
(FcγRIIIB), and CD66b. Although CD64 (FcγRI) was not detected on her neutrophils and 
monocytes, CD11b, CD11c and CD32 (FcγRII) were detectable equally on both cells 
(data not shown). Again, all of these characteristic features were quite similar to those of 
patient P2. Neutrophils from patient P2 showed more CD16 expression compared to P1. 
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Two amino acid deletion in bZIP and reduced transcriptional activity 
Direct sequence analysis revealed that patient P1 had a homozygous 6-bp deletion 
in exon 2 of the C/EBPε gene (c.739_744delCGCAGC). This novel mutation leads to a 
two aa deletion, p.Arg247_Ser248del (ΔRS), which is located in the bZIP domain (Fig. 3). 
The mutation was present in DNA isolated from both the peripheral blood and buccal 
mucosa, indicating a germline mutation, not a somatic one. Analysis of 100 alleles of 
ethnically matched healthy controls demonstrated the absence of the mutation in the 
general population.  
To evaluate the transcriptional activation by the ΔRS mutant, HEK293 cells were 
cotransfected with a G-CSF receptor promoter reporter construct and C/EBPε expression 
vectors. As shown in Fig. 4A, wild-type C/EBPε presented robust reporter activity, 
whereas the ΔRS mutant exhibited a significant decrease in activity, similar to the 
previously reported mutants, insA and del5bp (c.249_253delTGACC) (2, 3), both of 
which were frameshift mutations with truncated proteins. HEK 293 cells transfected with 
the ΔRS mutant expressed levels of C/EBPε comparable to wild type, as assessed by 
Western blot analysis, indicating ΔRS does not cause instability in the mutated C/EBPε 
protein (Fig. 4B). Increasing amounts of ΔRS had no negative effect on reporter activity 
of wild-type C/EBPε, indicating a lack of a dominant negative effect of ΔRS on 
transcriptional activity (Fig. 4C). We also analyzed the ability of the C/EBPε mutant 
proteins to activate gene expression of secondary granule genes. As shown in Fig. 4D, 
wild-type C/EBPε was able to induce expression of endogenous B9, NGAL, and 
lactoferrin genes in transiently transfected NIH3T3 cells. In contrast, none of these genes 
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was amplified from cells transfected with either the ΔRS mutant or the insA and del5bp 
mutants, consistent with loss of their capability to activate secondary granule genes. 
 
Unaltered cellular localization, DNA-binding and dimerization 
To understand the mechanism by which the ΔRS mutation decreases 
transcriptional activity, we first investigated the cellular localization of wild-type and 
mutant C/EBPε proteins. GFP fluorescence was diffusely detected within the cytoplasm 
of NIH3T3 cells transfected with the control GFP vector, whereas wild-type as well as 
ΔRS mutant C/EBPε tagged with GFP was found in the nucleus (Fig. 5). Consistent with 
the previous report (3), the insA mutant was localized in the cytoplasm as well as the 
nucleus; and a similar abnormal localization was detected in the del5bp. 
We next assessed the ability of the wild-type and mutant C/EBPε to bind to 
C/EBPε binding site at the 5’UTR of human lactoferrin gene (19). The oligonucleotides 
containing the C/EBPε binding site bound in vitro to C/EBPε from lysates of HEK293 
cells transfected with wild-type Myc-C/EBPε vector (Fig. 6, top left blot). Importantly, 
the ΔRS mutant showed DNA-binding ability comparable to the wild-type C/EBPε (Fig. 
6A, top right blot). Nonlabeled oligonucleotides of the same sequence, but not those with 
a mutated sequence, were able to compete with the biotinylated oligonucleotides for 
sequence specific binding of both the wild-type and ΔRS mutant C/EBPε. In contrast, no 
product was precipitated from lysates of cells transfected with the del5bp and the insA 
mutants, indicating that no oligonucleotide binding took place (Fig. 6A, bottom panels).  
 To assess further the functionality of the ΔRS mutant, we examined dimer 
formation in lysates of HEK293 cells cotransfected with Myc-C/EBPε and Flag-MBP-
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C/EBPε vectors. The ΔRS mutant was able to homodimerize or heterodimerize with wild-
type C/EBPε at levels comparable to wild-type C/EBPε (Fig. 6B and data not shown). 
These results were consistent with the ability of the ΔRS mutant to bind to DNA. 
 
Aberrant association with Gata1 and PU.1 
To determine whether the ΔRS mutant properly interacts with other proteins, 
cooperative transcriptional activation of MaBP was analyzed in NIH3T3 cells. Consistent 
with the previous report (15), MaBP gene expression was observed in cells transfected 
with Gata1 and PU.1 in addition to wild-type C/EBPε, and no products were obtained 
from those without wild-type C/EBPε (Fig. 7A). Interestingly, the ΔRS mutant, as well as 
the del5bp and the insA mutants, failed to induce MaBP gene expression. 
To assess further the ability of the C/EBPε mutants to bind to Gata1 as well as 
PU.1, the MBP pull-down assay was performed. As expected, both Gata1 and PU.1 were 
able to bind in vitro to C/EBPε in lysates of HEK293 cells transfected with the wild-type 
Flag-MBP-C/EBPε vector; and no binding was observed in lysates of cells transfected 
with the del5bp and the insA mutants (Fig. 7B,C). Some binding of the ΔRS mutant to 
Gata1 or PU.1 was indicated by the results, but the amounts of precipitated Gata1 and 





C/EBPε is essential for terminal differentiation of granulocytes. Frameshift 
mutations of the C/EBPε gene have been identified in two patients with SGD. Here, we 
report on a 55-year-old female (P1) affected with SGD caused by a novel 2-aa deletion 
mutation of the C/EBPε gene. This case represents a third case of genetically defined 
SGD. The availability of blood samples from the previous case (P2) offered us the unique 
opportunity to evaluate and compare phenotype of peripheral neutrophils in these patients. 
In addition to the morphological abnormalities typical for SGD, we found characteristic 
surface phenotype in their neutrophils including the presence of monocyte markers such 
as CD14 and the absence of neutrophil markers such as CD15, CD16b and CD66b. It is 
therefore difficult to distinguish neutrophils from monocytes by surface markers in the 
patients. CD16 includes two isoforms, CD16a (FcγRIIIA) and CD16b. CD16a is a 
transmembrane receptor expressed by monocytes, NK cells and NKT cells, whereas 
CD16b is a glycosylphosphatidylinositol-anchored receptor which is thought to be 
exclusively expressed by neutrophils. Because pan-CD16, but not CD16b was detected in 
a subset of the patient’s neutrophils, they likely expressed CD16a. Neutrophils from 
patient P2 showed higher levels of CD16 expression than those of patient P1, indicating a 
larger subpopulation of CD16a+ neutrophils. Human monocytes are divided into two 
major subsets, CD14++ CD16a- and CD14+ CD16a+ cells. Various inflammatory conditions 
including infections lead to an increased subpopulation of CD16a-positive monocytes (20, 
21). CD16 expression of neutrophils of patient P1 was associated with infections (data 
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not shown); therefore, CD16a expression on SGD neutrophils may depend on 
inflammatory immune stimuli. 
The reason why the patient’s neutrophils expressed monocyte markers, including 
CD14 and CD16a, is presently unclear. Studies of granulocytes from healthy volunteers 
who were given G-CSF and from human embryonic stem cells treated with multiple 
growth factors have demonstrated aberrant expression of CD14 on mature granulocytes 
(22, 23). Although we did not measure any soluble factors related to granulocytic 
differentiation in our patients, defective myeloid differentiation in SGD could lead to 
dysregulated secretion of growth factors resulting in aberrant surface expression of 
neutrophil proteins. In vitro modeling of neutrophil development in SGD using induced 
pluripotent stem cells will be required to address these issues. 
We carried out a comprehensive in vitro study to evaluate transcriptional activity, 
cellular localization, DNA-binding activity, dimerization and protein-interaction of the 
ΔRS mutant as well as the two frameshift mutants. All three mutants exhibited marked 
reduction in transcriptional activity. The ΔRS mutation is located in the bZIP domain, 
that is highly conserved among the C/EBP family members and has an important role in 
DNA binding and dimerization (5). However, the ΔRS mutant maintained normal cellular 
localization, DNA-binding activity and dimerization, in contrast to the frameshift 
mutations, del5bp and insA, which destroy the bZIP domain and thus are predicted to 
interfere with dimerization and binding to DNA. No dominant negative effect of the ΔRS 
mutant may suggest that the single normal C/EBPε allele is sufficient to maintain 
transcriptional activity, which is consistent with the fact that the mother and two children 
of patient P1, who are assumed to be heterozygous for the ΔRS mutation, remain in good 
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health. The association of C/EBPε with other transcription factors has been demonstrated 
to be important for the regulation of secondary granule gene expression in both 
neutrophils and eosinophils (15). In fact, the ΔRS mutant was found to be defective in 
association with Gata1 and PU.1, as well as aberrant cooperative transcriptional 
activation of eosinophil MaBP. Gata1 is primarily associated with erythroid and 
megakaryocyte differentiation, whereas PU.1 is more important for neutrophil 
differentiation. These results are in line with the fact that eosinophils were not detectable 
in patients P1 and P2. Taken together, our findings suggest that the ΔRS mutation impairs 
protein-protein interaction with Gata1 and with PU.1, resulting in loss of cooperative 
transcriptional activation.  
A similar mutation has been described in a patient with acute myeloid leukemia, 
in which an in-frame 3-bp deletion within the leucine zipper domain of C/EBPα 
abrogated the transcriptional activation function of C/EBPα on the G-CSF receptor 
promoter (24). Like the ΔRS mutant, this mutant lacked a dominant negative effect, 
although its protein-protein interaction with other transcription factors remained 
unexamined. Further investigation will be necessary to assess whether the ΔRS mutant 
also exhibit defective interaction with other transcription factors such as c-Myb, PML, 
p300, E2F1 and Rb (9, 16, 25, 26). Because certain isoforms of C/EBPε have been 
reported to inhibit the synergistic activities of GATA1 and PU.1 (25), we also need to 
evaluate the isoforms of the C/EBPε mutants other than the full length, 32 kDa C/EBPε. 
These characteristics of the ΔRS mutant, wherein modest association with Gata1 
and PU.1 is retained and nuclear localization remains intact, may be associated with less 
severe clinical symptoms of patient P1. To date, patient P1 has shown no deep organ 
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infection, whereas the other patients exhibited more severe presentation of the disease. 
The first reported patient with the del5bp mutation died from complications of 
pneumonia, and patient P2 suffered from recurrent pneumonia, as well as lung abscess (2, 
3). On the other hand, recurrent bacterial skin abscess that persisted a few months was 
observed in all of the patients with SGD including patient P1 (27). Skin abscess smears 
from patient P1 showed that most infiltrating cells were monocytes and macrophages, 
some of which phagocytosed bacteria (data not shown). Monocytes from C/EBPε-
deficient mice exhibited impaired maturation and altered cytokine expression, such as 
increased levels of TNF-α and LTβ, in response to inflammation (28, 29). In addition, 
monocyte counts in C/EBPε-deficient mice were higher than those of wild-type mice (30). 
Thus, impaired inflammatory response and killing of bacteria by SGD patients’ 
monocytes may hinder the healing process, resulting in unique skin abscesses. 
Understanding which factors evoke an abnormal microenvironment at infectious sites 
will be necessary to develop more effective therapeutic approaches for patients with SGD. 
In summary, our studies identified a novel in-frame deletional mutation in the 
bZIP domain of C/EBPε and demonstrated its molecular pathogenesis leading to SGD. 
Comparative analysis of the C/EBPε mutations, including the previous frameshift 
mutations, also clarifies the functional significance of these mutants. Characterization of 
C/EBPε genetic defects and functional abnormalities will help define the role of C/EBPε 
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FIGURE 1.  Patient characteristics.  (A, B) Skin abscess with ulceration and scar. (C) 
Peripheral blood smears. Neutrophils from patients P1 and P2 have bilobed nuclei and 
lack cytoplasmic granules (May-Grünewald-Giemsa staining). (D) Immunohistochemial 
analysis. Cytospin preparations of leukocytes stained with anti-lactoferrin mAb. Cellular 
alkaline phosphatase and peroxidase activity were also analyzed.  
 
FIGURE 2.  Characterization of granulocytes.  Granulocytes were gated for fluorescence 
analysis and the percentage of cells gated in each region is shown. 
 
FIGURE 3. Mutation analysis of C/EBPε gene.  (A) C/EBPε gene exon 2 was amplified 
from DNA extracted from normal control, as well as peripheral blood and buccal mucosa 
of patient P1. Direct sequencing was performed using an automated sequencer. A thick 
bar highlights the position of the 6-bp deletion (ΔRS). (B) Predicted structures of mutated 
C/EBPε molecules. The previously reported frameshift mutations, del5bp and insA, 
produced frameshifts that result in incorrect amino acid sequence subsequent to the 
mutations (shaded area) and premature termination. bZIP, basic-leucine zipper. 
 
FIGURE 4.  Transcriptional activity and induction of endogenous expression of granule 
genes.  (A) Luciferase reporter plasmid containing the G-CSF receptor promoter 
(pGCSFR-Luc) was transfected into HEK293 cells with either control empty (ev), wild-
type (WT), ΔRS, del5bp or insA C/EBPε expression vector.  Luciferase activity was 
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measured 48 h after transfection. Bars represent the means and standard deviations of 
triplicate assay. (B) Western blot analysis of C/EBPε was performed using lysates of 
HEK293 cells transfected with either ev, WT, ΔRS, del5bp or insA C/EBPε vector. (C) 
WT C/EBPε vector was mixed with increasing amounts of ΔRS C/EBPε vector and 
luciferase reporter assay was performed. (D) Expression vectors of ev, WT, ΔRS, del5bp 
or insA C/EBPε were transfected into NIH3T3 cells, and expression of endogenous B9, 
NGAL, and lactoferrin was examined by RT-PCR. GAPDH was used as a loading control. 
The numbers of PCR cycles were 20 for GAPDH, 30 for C/EBPε, B9 and NGAL, and 35 
for lactoferrin. 
 
FIGURE 5.  Cellular localization.  GFP-tagged to either control empty (ev), wild-type 
(WT), ΔRS, del5bp or insA C/EBPε expression vectors were transfected into NIH3T3 
cells, and cells were analyzed by microscopy and fluorescent microscopy two days after 
transfection. Nuclei were stained with Hoechst stain. Bar indicates 20 µm. 
 
FIGURE 6.  DNA binding activity and dimerization.  (A) DNA binding activity of WT, 
ΔRS, del5bp and insA C/EBPε. Biotin-labeled oligonucleotide containing the C/EBPε-
binding site of the lactoferrin gene was incubated with Myc-C/EBPε (WT, ΔRS, del5bp, 
or insA)-transfected HEK293 cell extracts either with or without 25-fold nonlabeled WT 
or mutated non-binding (Mu) oligonucleotide. Biotin-labeled oligonucleotides were 
pulled down by streptavidin-agarose. The precipitates and cell lysates were analyzed by 
Western blot analysis with anti-Myc Ab. (B) Dimer formation of ΔRS. HEK293 cells 
were transfected with Myc-C/EBPε-ΔRS together with either empty control vector 
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(MBP-ev), Flag-MBP-C/EBPε-WT or -ΔRS. MBP-fused proteins were pulled down by 
amylose resin, and the precipitates were analyzed by Western blot analysis with anti-Myc 
Ab. Expression of each protein was confirmed with anti-Myc and anti-Flag Abs, 
respectively. 
 
FIGURE 7.  Cooperative transcriptional activation of eosinophil major basic protein 
(MaBP).  (A) Induction of proteoglycan 2 (Prg2)/MaBP expression in NIH3T3 cell. 
Expression vectors Gata1 and PU.1 were transfected into NIH3T3 cells either with or 
without C/EBPε expression vectors (WT, ΔRS, del5bp or insA).  Expression of 
endogenous Prg2/MaBP mRNA was examined by RT-PCR. GAPDH was used as a 
loading control. The numbers of PCR cycles were 20 for GAPDH, and 25 for 
C/EBPε, Gata1, PU.1 and MaBP. (B) Protein interaction between Gata1 and C/EBPε WT 
or mutants. (C) Protein interaction between WT or mutants PU.1 and C/EBPε. HEK293 
cells were transfected with either Myc-Gata1 or Myc-PU.1 together with either an empty 
control vector (MBP-ev), Flag-MBP-C/EBPε-WT, -ΔRS, -del5bp or -insA. MBP-fused 
proteins were pulled down by amylose resin, and the precipitates were analyzed by 
Western blot analysis with anti-Myc Ab. Expression of each protein was confirmed with 
anti-Myc and anti-Flag Abs, respectively. 
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